1
Ma T, Wang Y, Huang C, Zhang X, An Y, Zhang Q, Kong Q, Cao B. Chimeric hBPI23-Fcγ protein shows bactericidal activity against drug-resistant Gram-negative bacteria and protects mice from lethal challenge. Arch Microbiol. 2025 Mar 28;207(5):103. doi: 10.1007/s00203-025-04306-2. PMID: 40152989.
2
Cao W#, Su W#, Song X#, Ma L#, Li Y#, Yan H, Li J, Yang J, Zhao J, Liu K, Qiu R, He G, Shi F, Wang J, Suo L, Liu X, Zhang Y, Li L, Zhao H, Li T, Yi G, Huang Z, Gao S, Wang Y*, Cao B*. Efficacy and Safety of WXSH0208 Tablets in Treatment of Acute Uncomplicated Influenza Infection in Adults: A Multicenter Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. J Infect Dis. 2025 Mar 25:jiaf075. doi: 10.1093/infdis/jiaf075. Epub ahead of print. PMID: 40131019.
3
Zhang R#, Yu J, Shang X, Wang Z, Li H*, Cao B*. Heterogeneity in clinical patterns of adult lung abscess patients: an 8-year retrospective study in a tertiary hospital. BMC Pulm Med. 2025 Mar 5;25(1):101. doi: 10.1186/s12890-025-03487-2. PMID: 40045326;
4
Yan Y#, Shang L#, Xu J, Gu X, Fan G, Wang Y, Cao B*. The prevalence and outcomes of viremia in patients with acute respiratory viral infection: a systematic review and meta-analysis. Clin Microbiol Infect. 2025 Jan 28:S1198-743X(25)00035-7. doi: 10.1016/j.cmi.2025.01.027. Epub ahead of print. PMID: 39884502.
5
Yan M#, Shang L#, Wang Y#, Wang C, Cao B*. Metagenomic next-generation sequencing on treatment strategies and prognosis of patients with lower respiratory tract infections: A systematic review and meta-analysis. Int J Antimicrob Agents. 2025 Jan 4;65(3):107440. doi: 10.1016/j.ijantimicag.2024.107440. Epub ahead of print. PMID: 39761759.
6
Zhuo X#, Lei Z, Pu D, Wu Y, Zhao J*, Cao B*. Hypervirulent Klebsiella pneumoniae have better clinical outcomes than classical Klebsiella pneumoniae for lower respiratory tract infection patients. BMC Microbiol. 2025 Jan 22;25(1):40. doi: 10.1186/s12866-024-03726-2. PMID: 39844054; PMCID: PMC11753108.
7
Wang Y#, Wang H#, Zhang Y#, Ma A#, Liu D#, Li X, Yang G, Deng M, Wang S, Liu Y, Liu C, Ge F, Wang S, Yu Y, Feng G, Xiao Z, Li X, Sun Y, Chen X, Cao Z, Ding Y, Wu X, Wei J, Cao B*. Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial. Nat Med. 2025 Jan 7. doi: 10.1038/s41591-024-03419-3.
8
Cao W#, Xu J#, Liu Z, Wang Z, Zhang X, Zhan Q*, and Cao B*. Poor clinical outcomes in respiratory viral sepsis: a retrospective observational study. ERJ Open Res 2024; in press doi:10.1183/23120541.00836-2024
9
Sheng W#, Huang L#, Gu X#, Wang Y, Jiang M, Hu C, Li J, Ran C, Zhang H, Wang N, Wang Y, Qi X, Suo L, Liu B, Pei G, He Z, Wang J*, Cao B*. Procalcitonin-guided use of antibiotic in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized clinical trial. Clin Microbiol Infect. 2024 Dec 9:S1198-743X(24)00590-1. doi: 10.1016/j.cmi.2024.12.004
10
Zou X#, Yan M#, Wang Y#, Ni Y, Zhao J, Lu B, Liu B*, Cao B*. Accurate Diagnosis of Lower Respiratory Infections Using Host Response and Respiratory Microbiome from a Single Metatranscriptome Test of Bronchoalveolar Lavage Fluid. Adv Sci (Weinh). 2024 Dec 18:e2405087. doi: 10.1002/advs.202405087.
11
Xu J#, Wang Y#, Zhang Y, Zhai T, Li Z, Zhong D, Cao B, Cui X*. A case of adult-onset X-linked lymphoproliferative disease mimicking pulmonary infection. BMC Infect Dis. 2024 Dec 18;24(1):1399. doi: 10.1186/s12879-024-10281-8.
12
Procalcitonin-guided use of antibiotic in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized clinical trial. Clinical Microbiology and Infection. Available online 9 December 2024. (https://doi.org/10.1016/j.cmi.2024.12.004)
13
Xu J, Zhang H, Wang Y, Wang S, Cao B*. Chronic Active SARS-CoV-2 in B-cell Immunodeficiency. The Innovation Medicine. 2024 doi: 10.59717/j.xinn-med.2024.100071
14
宋融融, 徐九洋, 刘智博, 曹彬. 雷帕霉素在甲型H1N1流感病毒感染中对糖酵解和炎性因子的调节作用. 国际呼吸杂志. 2024年2月第44卷第2期. DOI: 10.3760/cma.j.cn131368-20240102-00001
16
Guo L, Zhang Q, Gu X, Ren L, Huang T, Li Y, Zhang H, Liu Y, Zhong J, Wang X, Chen L, Zhang Y, Li D, Fang M, Xu L, Li H, Wang Z, Li H, Bai T, Liu W, Peng Y, Dong T, Cao B, Wang J. Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19: a longitudinal cohort study. Lancet Microbe. 2024 Jan;5(1):e24-e33. doi: 10.1016/S2666-5247(23)00255-0.
